Evidence for an association of HLA-DRB1*15 and DRB1*09 with leprosy and the impact of DRB1*09 on disease onset in a Chinese Han population. (1/11)

 (+info)

Genomewide association study of leprosy. (2/11)

 (+info)

Use of the ML-Flow test as a tool in classifying and treating leprosy. (3/11)

 (+info)

Profile of patients affected by Hansen's disease seen at the Outpatient Clinic of Dermatology at Hospital Evangelico de Curitiba. (4/11)

 (+info)

Epidemiological, clinical, and operational aspects of leprosy patients assisted at a referral service in the state of Maranhao, Brazil. (5/11)

 (+info)

Quality of life of patients with paucibacillary leprosy. (6/11)

 (+info)

Concordance between expected and observed bacilloscopy results of clinical forms of leprosy: a 6-year retrospective study in Recife, State of Pernambuco, Brazil. (7/11)

 (+info)

A clinical trial for uniform multidrug therapy for leprosy patients in Brazil: rationale and design. (8/11)

 (+info)